Evaluation of EU Post-Authorization Safety Studies Using Recent EU-RMP Summary Data: Analysis, Trends, Implications
January 29, 2014 from 10AM to 11AM EST
This Webcast will provide an overview of recent trends in EU PASS, including an analysis of a sample of EU-RMP summary data, description of PASS types requested and comparison/contrast of characteristics between drug types.
Implications for Pharmaceutical Companies and lessons learnt will be discussed
Register Free at http://www.pharmexec.com/eu_rmp
New Industry Research: Transforming Clinical R&D Strategy and Performance with Real-World Data
February 13, 2014 from 11AM to Noon EST
Join speakers from the Tufts Center for the Study of Drug Development, Oracle Health Sciences, and Context Matters to explore how protocol and trial designs can be optimized not only for greater R&D efficiency but also to discover health economic outcomes with clinical outcomes.
Register Free at http://www.pharmexec.com/performance
ON-DEMAND WEBCASTS NOW AVAILABLE FOR REPLAY
Pre-Approval Risk Mitigation Strategies and Proactive Safety Considerations
Recorded on: December 10, 2013
Discover ways biopharmaceutical companies can proactively prepare during drug development to monitor and assess patient safety in the postapproval period.
Register Free at http://www.pharmexec.com/preapproval
UBC Express Scripts
An Intro to Utility Assessment Methods
Recorded on: December 5, 2013
This webinar will provide an introduction to utility theory and utility assessment methods with select case studies, in addition to a discussion of the influence of the National Institute of Clinical Excellence (NICE) on utility assessment. We will focus on direct utility assessment, indirect utility assessment (multi-attribute measures and condition – specific measures), deriving utilities from condition-specific measures, and mapping methods.
Register Free at http://www.pharmexec.com/utility
Avoid the Last Minute Rush-Planning Ahead for Successful Global Market Access
Recorded on: November 20, 2013
Successful market access is never easy, but waiting too long to plan for it can make life harder than it need be. In our experience, while there are companies that plan well, too few do this at the right time in the product development lifecycle. There are always difficult questions to be addressed and a range of uncertainties that must be considered in approaching global market access and the associated evidence generation activities. In this webcast, we:
- Highlight some of the common pitfalls to avoid
- Outline a process that will ensure key questions are addressed (but won’t guarantee commercial success!)
- Provide case studies to illustrate sensible planning for evidence generation activities
Register Free at http://www.pharmexec.com/rush
Oncology Data Management Innovations
Recorded on: November 20, 2013
Join us for a webinar highlighting innovations in data and information management specifically for Oncology. Oncology commercial teams today continue to face several important issues, including data gaps due to specialty distribution, small patient counts at local levels, integrating data across infusion and pharmacy channels, understanding product usage across multiple indications, and more.
Register Free at http://www.pharmexec.com/datamgmt
Let the Sunshine In: What Executives Need to Know as the Open Payments Program is Fully Implemented
Recorded on: November 14, 2013
Life Sciences companies must constantly identify and monitor the corporate, reputational, and personal liability risks inherent in their worldwide business activities. The Open Payments program has placed a renewed focus on the relationship between the Life Sciences industry and the healthcare provider community. While the intent of the law is to provide direct insight and transparency into these relationships, the data will ultimately serve as a tool to identify non-compliance by regulators, business intelligence by competitors and potentially controversial analyses by the media - ultimately exposing the company to greater risk across the board. The time to act is now—companies ahead of the pack are considering the various types of scenarios that could potentially increase corporate and executive risks and they are taking action.
Register Free at http://www.pharmexec.com/openpayments
Huron Life Sciences
Pharma's Shift to Custom Solutions Marketing
Recorded on: October 31, 2013
eHealthcare Solutions, experts in digital healthcare marketing with vast experience in building programs that drive results, shares insights about the latest options in custom digital programs targeting physicians/HCPs.
Hear these innovators provide tips on:
- Invigorating your marketing campaigns
- Engaging highly valuable audiences at the right time
- Achieving Maximum Brand Impact and measurable ROI
Register Free at http://www.pharmexec.com/custom
Integrated Strategies for Oncology Provider Engagement
Recorded on: October 30, 2013
During this presentation, we will examine how industry trends are impacting the way Pharmaceutical and Biotech companies interact with physicians, and how to implement strategies to optimize engagement with providers. Specifically, we will discuss:
• Key industry trends impacting oncology providers
• How to implement strategies that foster strong relationships with providers
• New approaches to deliver relevant and timely information to providers
Register Free at http://www.pharmexec.com/provider_engagement
Improving Clinical Trial Management with cloud-based eTMF
Join industry thought leaders, Rik van Mol of Veeva Systems and Eldin Rammell as they share valuable insights on how you can improve your clinical operations efficiency to significantly improve your clinical trial management process. Leading functional CRO, International Drug Development Institute (IDDI), will share their thoughts on how a cloud-based eTMF solution is helping improve their quality and document management processes and enhancing audit management.
Register Free at www.pharmexec.com/etmf
Rare diseases: Evidence, Value, Insight
Recorded on: October 2, 2013 / 10:00am - 11:00am EDT
The past decade has seen numerous innovations in novel therapies for rare diseases, providing clinical and humanistic benefits for populations that are small but have large unmet need. Payers and manufacturers alike recognize the high price of innovation, and healthcare systems have struggled in recent years to manage the budget impact of life-changing treatments for patients with rare diseases
Register Free at www.pharmexec.com/raredisease
Increase the Value of Database Research with Validated Coding Algorithms
Recorded on: September 18, 2013, 10:00EDT
In today?s research environment, the employment of high quality methods for retrospective database research has never been more relevant. Database publications continue to significantly increase over time for both claims database and electronic medical record (EMR) database studies, and initiatives such as the Observational Medical Outcomes Partnership (OMOP) and Mini-Sentinel as well as large safety-based studies in the U.S. and Europe have focused their efforts in the area of epidemiological and safety-based research. This webinar will focus on the how the identification and development of validated coding algorithms are used in defining study cohorts, health outcomes of interest, as well as patient comorbidities, and the opportunities and challenges of using these algorithms in database research.
Register Free at www.pharmexec.com/increase
ClinRO Development Approaches
Recorded on: July 16, 2013 from 10AM to 11AM EDT
The purpose of this webinar is to discuss the development of new clinician-reported outcomes for application in clinical development programs and clinical practice. We will cover state-of-the-science clinician-reported outcome instrument development and psychometric evaluation methods, with emphasis on practical considerations, and rater training and certification approaches.
Register Free at http://www.pharmexec.com/clinro
Strategies for Implementing Risk Minimization in Europe
Recorded on: July 17, 2013 from 9-10AM EDT
If there are no “one size fits all” risk management strategies in the EU, how are manufacturers successfully navigating multiple regulatory agencies and healthcare systems to implement programs across the continent? Janine Collins, M.D., Senior Director, European Risk Management, UBC, will explore best practices for preparation, implementation and assessment of multi-country European risk minimization measures.
Register Free at http://www.pharmexec.com/europe
UBC Express Scripts
The Social Media Landscape: Best In Class
Thursday, July 18, 2013 from 1-2PM EDT
Join Klick Health's Jay Goldman, Brad Einarsen and Mark Bard of the Digital Health Coalition on a comprehensive review of THE BEST IN CLASS practices in the world of social media for those in healthcare.
Register Free at http://www.pharmexec.com/bestinclass
Multi-Criteria Decision Analysis (MCDA): The Key to Successful Product Development and Market Access
Recorded on: June 27, 2013
How can Multi-Criteria Decision Analysis (MCDA) help maximize the probability of successful product development and market access? Learn how to implement MCDA to support internal investment decisions and facilitate the communication of value messages to payers? Learn from examples of MCDA previously undertaken in healthcare.
Register Free at http://www.pharmexec.com/mcda
Retrospective Chart Review Studies: Application of Methodology to Evaluate Burden of Illness, Drug Utilization and Safety
Recorded on: Tuesday, May 14, 2013
Did you know that chart review studies can be used to gather real world data in support of burden of illness, patterns of care and drug utilization and safety evaluations? Join us to learn more about how chart review studies can help you meet your real-world evidence gathering goals and objectives.
Register Free at http://www.pharmexec.com/burden
UBC Express Scripts
Verifying Your Aggregate Spend Program and Transparency Reports
Recorded on: Tuesday, April 30, 2013
Huron Life Sciences’ Aggregate Spend experts will provide attendees with concrete takeaways to enhance their aggregate spend capture and reporting capabilities through verification tasks to meet the requirements of OpenPayments. Additionally, attendees will be given ideas on next steps in creating their internal auditing and monitoring programs as well as disciplinary action for increased adherence to OpenPayments requirements.
Register Free at http://www.pharmexec.com/aggspend
Huron Life Sciences
New models of cancer research in the age of personalized medicine
Recorded on: April 17, 2013
In the age of personalized medicine, an effective patient identification approach coupled with streamlined operational processes is crucial to meeting enrollment goals for clinical trials in oncology. Join Lisa Holland, Senior Director of Clinical Development at US Oncology Research, for a discussion about the key factors that drive successful clinical study start up and execution.
Register Free at http://www.pharmexec.com/personalized
Engage Nurse Practitioners through their Trusted Destination- “Generation NP”
Recorded on: March 26, 2013
Need to reach 40,000+ Nurse Practitioners with prescribing rights immediately? Let us show you how to effectively and efficiently accomplish this goal by utilizing Generation NP.
Register Free at http://www.pharmexec.com/generationnp
Accelerate Your Brand’s Growth With Connectivity Into the Community Pharmacy
Recorded on: March 20, 2013
Pharmaceutical brand teams are faced with a variety of challenges that inhibit their brand’s growth. Join this webinar to learn how the community pharmacy – with its direct access to prescribers and patients – can be a key partner in helping brand teams overcome many of these challenges to invigorate market share growth.
Register Free at http://www.pharmexec.com/community
Leveraging New Pharma Technologies to Improve the Customer Experience
Recorded on: February 27, 2013
Improving the customer experience for any pharma brand will be a top priority in 2013. Leveraging new pharma technologies will not only help you reduce costs but improve customer relationships.
Register Free at http://www.pharmexec.com/experience
Innovative Approaches to Database Study Design and Analysis: Opportunities and Challenges
Recorded on: January 31, 2013
Navigating medical products successfully to market and beyond is highly complex – compounded by the fact that understanding the needs and criteria of stakeholders (whether Regulatory, Payer, Patient or Prescriber) often requires substantial effort and strategic thinking. Anticipating stakeholder needs for effective planning allows for evidence to be produced that will be of value to stakeholders. With the changing Regulatory and Payer environment ,what are the implications for database study design and analysis in the future?
This webinar explores these issues, highlighting opportunities, challenges, presenting real world examples and providing practical guidance.
Register Free at http://www.pharmexec.com/approaches
Liberating Mobile Technology
Recorded on: January 23, 2013
- Mobile technology’s role in aligning GPs and sales representatives in the fight against the disease or condition.
- How interactive dialogue can be tailored to each physician's needs for richer, pull driven conversations.
- Understanding the closed loop analytics platform, an enabler for knowledge transfer and dialogue.
Register Free at http://www.pharmexec.com/liberating